| |
NewswireToday - /newswire/ -
Owings Mills, MD, United States, 02/21/2008 - Sterilex today announces that Mark E. Wozniak, Ph. D. has been appointed Director of Research and Development, effective immediately.
|
| |
Prior to joining Sterilex, Dr. Wozniak held a variety of positions at J.M. Huber Corporation including Director of Quality and Senior R&D Manager. Dr. Wozniak is a proven leader in directing R&D initiatives and has experience guiding process improvement initiatives, leading business transformations and overhauling manufacturing procedures. At Sterilex, Dr. Wozniak will guide Sterilex’s R&D initiatives into safer, more effective anti-biofilm and antimicrobial technologies. He received his Bachelor of Science degree in Chemistry from the University of Michigan and his Ph. D. in Inorganic Chemistry from The Pennsylvania State University.
“We are very excited that Dr. Wozniak will be leading Sterilex’s innovation programs, and we look forward to working with him to continue Sterilex’s commitment to the development of innovative solutions for microbial control.” said Dr. Shira Kramer, President of Sterilex.
“I am honored by the opportunity to join the strong team at Sterilex and look forward to helping Sterilex develop innovative solutions that fortify its leadership position in markets it services.” Dr. Wozniak said.
About Sterilex Corporation
Sterilex Corporation (sterilex.com) is a leader in developing patented antimicrobial and anti-biofilm products for infection control, the decontamination of pathogens, spoilage organisms and resistant biofilms. The Sterilex product line includes EPA-registered antimicrobial products for biofilm and pathogen control, as well as specialty cleaning and decontaminating agents. Sterilex sells disinfectants, anti-biofilm biocides, cleaning, and decontaminating products to the health care, dental care, water care, industrial, food processing, and environmental remediation industries.
|
alex[.]sterilex.com 
